久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Boston Scientific to sell BTG Specialty Pharmaceuticals business for $800m pharmaceutical-technology
    December 03, 2020
    Boston Scientific has signed a definitive agreement with SERB’s affiliates, Stark International and SERB SAS, to divest its BTG Specialty Pharmaceuticals business for $800m in cash.
  • Recipharm, SERB Enter Agreement contractpharma
    June 19, 2018
    Recipharm?has signed and closed an agreement with?SERB SA?(“SERB”) on a divestment of its rights to its potassium iodide product ThyroSafe? except for the US territory.?

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service